ELAN - SRPT SE ELAN among premarket losers August, 20 2019 09:15 AM Elanco Animal Health Incorporated Synlogic (NASDAQ:SYBX) -25% in reaction to its decision to terminate development of SYNB1020 for the treatment of hyperammonemia.More news on: Synlogic, Inc., Sarepta Therapeutics, Inc., Fabrinet, Stocks on the move, Read more ...